Access to antihypertensive agents in Brazil: Evaluation of the "health has no price" program

Clinical Therapeutics

Volumn 36, Issue 8, 2014, Pages 1191-1195

  Araujo, João Leopoldo Oliveira ^a   Pereira, Mariana Donato ^a   De Sá Del Fiol, Fernando ^a   Barberato Filho, Silvio ^a  

^a UNIVERSITY OF SOROCABA   (Brazil)

Author keywords

access to health services; antihypertensive agents; cardiovascular; health policy; health system

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BRAZIL; CLINICAL PHARMACY; CONCENTRATION (PARAMETERS); DRUG INDUSTRY; EVALUATION STUDY; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH HAS NO PRICE PROGRAM; HEALTH PROGRAM; HUMAN; MEDICAL CARE; OBSERVATIONAL STUDY; PILL; COMMERCIAL PHENOMENA; ECONOMICS; FEE; HYPERTENSION; LONGITUDINAL STUDY; MEDICINAL CHEMISTRY; PROGRAM EVALUATION; SUPPLY AND DISTRIBUTION; TRENDS;

ANTIHYPERTENSIVE AGENTS; BRAZIL; CHEMISTRY, PHARMACEUTICAL; COMMERCE; FEES, PHARMACEUTICAL; HEALTH SERVICES ACCESSIBILITY; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; PROGRAM EVALUATION;

EID: 84906936444     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2014.06.003     Document Type: Article

References (20)

1. J. Paim, C.F. Travassos, and C.F. Almeida et al. The Brazilian health system: history, advances, and challenges Lancet 377 2011 1778 1797
2. F.S. Vieira Pharmaceutical assistance in the Brazilian public health care system Rev Panam Salud Public 27 2010 149 156
3. Instituto de Pesquisa Econômica Aplicada. Programas de Assistência Farmacêutica do Governo Federal: evolução recente das compras diretas de medicamentos e primeiras evidências de sua eficiência, 2005-2008. Brasília: IPEA; 2011. http://repositorio. ipea.gov.br/bitstream/11058/1201/1/td-1658.pdf. Accessed December 30, 2013.
4. The world medicines situation. Geneva: World Health Organization; 2004.
5. M. Bigdeli, B. Jacobs, and G. Tomson et al. Access to medicines from a health system perspective Health Policy Plan 28 2013 692 704
6. Pan American Health Organization. Access to High-Cost Medicines in the Americas: Situation, Challenges and Perspectives. Washington: PAHO; 2010. http://apps.who.int/medicinedocs/documents/s19112en/s19112en.pdf. Accessed December 30, 2013.
7. B. Jacobs, P. Ir, and M. Bigdeli et al. Addressing access barriers to health services: an analytical framework for selecting appropriate interventions in low-income Asian countries Health policy plan 27 2012 288 300
8. Brazil. Portaria n. 491, 9 March 2006. Providing for the expansion of the "Popular Pharmacy of Brazil" Program. Brasília: Brazil; 2006. http://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?jornal=1&pagina= 59&data=10/03/2006. Accessed December 30, 2013.
9. Brazil. Portaria n. 184, 3 February 2011. Providing for the "Popular Pharmacy of Brazil" Program]. Brasília: Brazil; 2011. http://pesquisa.in.gov.br/imprensa/jsp/visualiza/index.jsp?jornal=1&pagina= 35&data=04/02/2011. Accessed December 30, 2013.
10. B. Pratt, and B. Loff The Contribution of Product Development Partnerships to Access to Medicines and Research Capacity Building Lancet 380 2012 S19
11. A. Cameron, M. Ewen, and D. Ross-Degnan et al. Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis Lancet 373 2009 240 249
12. EMS report. Departamento de Treinamento e Desenvolvimento de Vendas. Tudo o que você precisava saber sobre: Programa Farmácia Popular. Campinas: Depto. de Treinamento e Desenvolvimento de Vendas EMS; 2013. http://pdfcast.org/download/manual-de-treinamento.pdf. Accessed December 30, 2013
13. Brasil. Ministério da Saúde. National list of essential medicines: Rename. Brasília: MS; 2010. http://portal.saude.gov.br/portal/ arquivos/pdf/rename2010final.pdf. Accessed December 30, 2013.
14. Brasil. Ministério da Saúde. National list of essential medicines: Rename. Brasília: MS; 2012. http://portal.saude.gov.br/portal/ arquivos/pdf/CONITECPORTARIAMS5332012.pdf. Accessed December 30, 2013.
15. E.I. Macedo, L.C. Lopes, and S. Barberato-Filho A technical analysis of medicines request-related decision making in Brazilian courts Rev Saude Publica 45 2011 706 713
16. A.P. Helfer, A.L. Camargo, N.U.L. Tavares, P. Kanavos, and A.D. Bertoldi Affordability and availability of drugs for treatment of chronic diseases in the public health care system Rev Panam Salud Publica 31 2012 225 232 http://dx.doi.org/10.1590/S1020-49892012000300007 (PMID:22569697)
17. Ministério da Saúde. Health Has No Price: Free Access to medicines grows 273%. Brasília: MS; 2012. http://www.brasil.gov.br/saude/ 2012/01/acesso-a-medicamentos-gratuitos-cresce-273. Accessed December 30, 2013.
18. Ministério da Saúde. Room to Support the Strategic Management of the Ministry of Health: Health Indicators at a click. Brasília: MS; 2013. http://189.28.128.178/sage/. Accessed December 30, 2013.
19. S. Dal Pizzol Tda, and D.J. Trevisol et al. Adherence to essential medicines in cities from three Brazilian states Cad Saude Publica 26 2010 827 836
20. H.V. Hogerzeil, J. Liberman, and V.J. Wirtz et al. Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration Lancet 381 2013 680 689